Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Page 1
Co-occurrence between hereditary angioedema and multiple sclerosis: Therapeutic management of both diseases with fingolimod.
Vakrakou AG, Tzanetakos D, Giagkou E, Evangelopoulos ME, Anagnostouli M, Andreadou E, Koutsis G, Dimitrakopoulos A, Gialafos E, Tzartos JS, Kompoti E, Fragoulis GE, Stefanis L, Kilidireas C. Vakrakou AG, et al. Among authors: dimitrakopoulos a. Clin Neurol Neurosurg. 2022 May;216:107222. doi: 10.1016/j.clineuro.2022.107222. Epub 2022 Mar 28. Clin Neurol Neurosurg. 2022. PMID: 35378480
Remission of MS and significant amelioration of HAE attacks were achieved under fingolimod treatment. CONCLUSIONS: Herein we provide long term evaluation of an extremely rare case of concomitant existence of HAE and MS and present the effects of MS current disease-modifyin …
Remission of MS and significant amelioration of HAE attacks were achieved under fingolimod treatment. CONCLUSIONS: Herein we provide long …
Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases.
Vakrakou AG, Tzanetakos D, Evangelopoulos ME, Argyrakos T, Tzartos JS, Anagnostouli M, Andreadou E, Koutsis G, Velonakis G, Toulas P, Gialafos E, Dimitrakopoulos A, Psimenou E, Stefanis L, Kilidireas C. Vakrakou AG, et al. Among authors: dimitrakopoulos a. Ther Adv Neurol Disord. 2021 May 18;14:17562864211006503. doi: 10.1177/17562864211006503. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34046086 Free PMC article.
Groups F (n = 2) and G (n = 4) involved MS patients who developed TDL during drug initiation (natalizumab, fingolimod) and cessation (interferon, fingolimod), respectively. Regarding long-term treatments applied after corticosteroid administration in the acute phase, B-cel …
Groups F (n = 2) and G (n = 4) involved MS patients who developed TDL during drug initiation (natalizumab, fingolimod) and cessation (interf …
Greece reports prototype intervention with first peripherally inserted central catheter: case report and literature review.
Konstantinou EA, Stafylarakis E, Kapritsou M, Mitsos AP, Fotis TG, Kiekkas P, Mariolis-Sapsakos T, Argyras E, Nomikou IT, Dimitrakopoulos A. Konstantinou EA, et al. Among authors: dimitrakopoulos a. J Vasc Nurs. 2012 Sep;30(3):88-93. doi: 10.1016/j.jvn.2012.03.001. J Vasc Nurs. 2012. PMID: 22901447 Review.
A description of all the technical details of this insertion is reported, focusing on the pros and cons of the method and a thorough review of the history and advances in central venous catheterization throughout the years is also presented. PICCs provide long-term intrave …
A description of all the technical details of this insertion is reported, focusing on the pros and cons of the method and a thorough review …
Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse.
Rentzos M, Nikolaou C, Rombos A, Evangelopoulos ME, Kararizou E, Koutsis G, Zoga M, Dimitrakopoulos A, Tsoutsou A, Sfangos C. Rentzos M, et al. Among authors: dimitrakopoulos a. Clin Neurol Neurosurg. 2008 Dec;110(10):992-6. doi: 10.1016/j.clineuro.2008.06.005. Epub 2008 Jul 25. Clin Neurol Neurosurg. 2008. PMID: 18657352 Clinical Trial.
CONCLUSIONS: The clinical improvement of our MS patients with relapse following the treatment with methylprednisolone may be associated with an immediate but not a long-term modification of serum levels of IL-10 and CCL2. IL-12 may not be influenced by steroid treatment... …
CONCLUSIONS: The clinical improvement of our MS patients with relapse following the treatment with methylprednisolone may be associated with …
Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.
Tsavaris N, Skarlos D, Bacoyiannis C, Aravantinos G, Kosmas C, Retalis G, Panopoulos C, Vadiaka M, Dimitrakopoulos A, Kostantinidis K, Mitropoulos D, Bougas D, Pantazopoulos D, Kosmidis P. Tsavaris N, et al. Among authors: dimitrakopoulos a. J Interferon Cytokine Res. 2000 Aug;20(8):685-90. doi: 10.1089/10799900050116381. J Interferon Cytokine Res. 2000. PMID: 10954911 Clinical Trial.
It is concluded that combined treatment with low-dose IFN and VBL, without loss of short-term efficacy, is better tolerated and less expensive than high-dose IFN monotherapy....
It is concluded that combined treatment with low-dose IFN and VBL, without loss of short-term efficacy, is better tolerated and less …